Table 2.

Effect of NS-187 and imatinib on the in vitro phosphorylation of purified wt and point mutated Abl kinase domains



IC50, nM
Abl kinase
NS-187
Imatinib
Wild type   72   1 100  
M244V   240   3 500  
G250E   160   2 000  
Q252H   410   2 100  
Y253F   81   1 500  
E255K   540   5 800  
E255V   1 400   > 10 000  
T315I   > 10 000   > 10 000  
F317L   760   1 900  
M351T   150   3 900  
E355G   580   7 100  
E359V   1 300   > 10 000  
H396P   95   1 400  
F486S
 
470
 
9 500
 


IC50, nM
Abl kinase
NS-187
Imatinib
Wild type   72   1 100  
M244V   240   3 500  
G250E   160   2 000  
Q252H   410   2 100  
Y253F   81   1 500  
E255K   540   5 800  
E255V   1 400   > 10 000  
T315I   > 10 000   > 10 000  
F317L   760   1 900  
M351T   150   3 900  
E355G   580   7 100  
E359V   1 300   > 10 000  
H396P   95   1 400  
F486S
 
470
 
9 500
 

The purified Abl kinase domains were subjected to in vitro kinase assays as described in “Materials and methods.” The enzyme concentration was 10 nM.

or Create an Account

Close Modal
Close Modal